Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Liabilities and Shareholders Equity (2022 - 2025)

Core Laboratories' Liabilities and Shareholders Equity history spans 4 years, with the latest figure at $584.0 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity changed 0.19% year-over-year to $584.0 million; the TTM value through Dec 2025 reached $2.4 billion, down 0.51%, while the annual FY2025 figure was $584.0 million, 0.19% changed from the prior year.
  • Liabilities and Shareholders Equity reached $584.0 million in Q4 2025 per CLB's latest filing, down from $591.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $602.1 million in Q2 2025 to a low of $570.2 million in Q3 2022.
  • Average Liabilities and Shareholders Equity over 4 years is $590.0 million, with a median of $591.5 million recorded in 2025.
  • Peak YoY movement for Liabilities and Shareholders Equity: increased 4.21% in 2023, then fell 1.52% in 2025.
  • A 4-year view of Liabilities and Shareholders Equity shows it stood at $578.4 million in 2022, then grew by 1.39% to $586.4 million in 2023, then decreased by 0.22% to $585.1 million in 2024, then decreased by 0.19% to $584.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Liabilities and Shareholders Equity are $584.0 million (Q4 2025), $591.4 million (Q3 2025), and $602.1 million (Q2 2025).